ITM Isotopen Technologien München Company Profile: Funding & Investors

ITM Isotopen Technologien München Overview

Founded
2004

Status
Private

Employees
50

Latest Deal Type
Debt

Financing Rounds
5

ITM Isotopen Technologien München General Information

Description

Developer of novel radiopharmaceuticals and radiomedical devices. The company design and develops novel radiopharmaceuticals and radiomedical devices. The company products are rhenium-SCT for non-invasive skin cancer therapy and ITM rhenium-PTA/PTCA for endovascular brachytherapy.

Contact Information

Website

itm-radiopharma.com

Ownership Status

Privately Held (backing)

Financing Status

Private Equity-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Surgical Devices

Therapeutic Devices

Primary Office

Lichtenbergstraße 1
85748 Munich
Germany

+49 089 0000000000







ITM Isotopen Technologien München Timeline

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ITM Isotopen Technologien München Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore ITM Isotopen Technologien München‘s full profile, request access.

Request a free trial

ITM Isotopen Technologien München Executive Team (5)

Name	Title	Board Seat	Contact Info
Steffen Schuster	Chief Executive Officer & Chairman
Thomas Dürre	Chief Financial Officer
Mark Harfensteller Ph.D	Head, Research & Development & Managing Director of ITG
Richard Henkelmann Ph.D	Managing Director
Philip Harris Ph.D	Chief Medical Officer